Total Payments
$959.98
2019 Payments
$20.46
Companies
19
Transactions
74
Medicare Patients
6,438
Medicare Billing
$396,927
Payment Breakdown by Category
Food & Beverage$874.98 (91.1%)
Education$85.00 (8.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $874.98 | 73 | 91.1% |
| Education | $85.00 | 1 | 8.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $203.66 | 8 | $0 (2017) |
| PFIZER INC. | $151.76 | 21 | $0 (2017) |
| Novo Nordisk Inc | $132.82 | 10 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $117.42 | 10 | $0 (2017) |
| GlaxoSmithKline, LLC. | $79.45 | 6 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $48.79 | 3 | $0 (2017) |
| Allergan Inc. | $30.99 | 2 | $0 (2017) |
| Lilly USA, LLC | $26.99 | 2 | $0 (2017) |
| Purdue Pharma L.P. | $21.19 | 2 | $0 (2017) |
| Covidien LP | $20.46 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $20.46 | 1 | Covidien LP ($20.46) |
| 2017 | $939.52 | 73 | Astellas Pharma US Inc ($203.66) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2017 | Gilead Sciences Inc | — | Food and Beverage | In-kind items and services | $10.90 | General |
| 03/08/2017 | Circassia Pharmaceuticals Inc | NIOX VERO DEVICE (Device) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: ALLERGY AND ASTHMA | ||||||
| 03/07/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $9.71 | General |
| Category: Diabetes | ||||||
| 02/28/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $10.73 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/28/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/27/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
| 02/23/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: Diabetes | ||||||
| 02/20/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: RESPIRATORY | ||||||
| 02/15/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $7.34 | General |
| Category: DIABETES | ||||||
| 02/14/2017 | PFIZER INC. | LYRICA (Drug) | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 02/13/2017 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/03/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Urology | ||||||
| 02/02/2017 | Valeant Pharmaceuticals North America LLC | RELISTOR ORAL (Drug), XIFAXANIBSD | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/02/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: DIABETES | ||||||
| 01/31/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Diabetes | ||||||
| 01/31/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/30/2017 | PFIZER INC. | ELELYSO (Drug) | Food and Beverage | In-kind items and services | $0.40 | General |
| Category: METABOLIC DISEASE | ||||||
| 01/23/2017 | Takeda Pharmaceuticals America, Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $12.93 | General |
| Category: Lower GI | ||||||
| 01/16/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Diabetes | ||||||
| 01/16/2017 | Purdue Pharma L.P. | BUTRANS (Drug), OXYCONTIN, HYSINGLA ER | Food and Beverage | Cash or cash equivalent | $10.42 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/12/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Urology | ||||||
| 01/09/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: RESPIRATORY | ||||||
| 01/04/2017 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: DIABETES | ||||||
| 01/03/2017 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 27 | 1,610 | 1,789 | $233,765 | $88,026 |
| 2022 | 26 | 1,682 | 1,822 | $234,430 | $104,320 |
| 2021 | 21 | 1,515 | 1,659 | $190,826 | $98,613 |
| 2020 | 23 | 1,631 | 1,847 | $254,508 | $105,968 |
Total Patients
6,438
Total Services
7,117
Medicare Billing
$396,927
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 21 | 88 | $660.00 | $65.98 | 10.0% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 12 | 20 | $400.00 | $6.46 | 1.6% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2022 | 32 | 33 | $396.00 | $3.20 | 0.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 346 | 368 | $47,472 | $28,873 | 60.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 200 | 200 | $42,800 | $19,472 | 45.5% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 254 | 263 | $22,355 | $11,895 | 53.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 172 | 175 | $16,100 | $10,609 | 65.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 75 | 84 | $16,296 | $9,829 | 60.3% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 76 | 76 | $11,020 | $6,115 | 55.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 38 | 38 | $11,742 | $5,740 | 48.9% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 89 | 92 | $6,532 | $2,559 | 39.2% |
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 17 | 17 | $1,700 | $1,249 | 73.5% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2021 | 18 | 18 | $2,520 | $531.42 | 21.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 36 | 38 | $1,976 | $472.60 | 23.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 22 | 22 | $2,376 | $275.10 | 11.6% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 13 | 13 | $923.00 | $214.89 | 23.3% |
| 94640 | Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen | Office | 2021 | 17 | 17 | $1,173 | $208.16 | 17.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 15 | 15 | $1,410 | $158.40 | 11.2% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 12 | 12 | $528.00 | $152.82 | 28.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 48 | 52 | $1,664 | $117.00 | 7.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 24 | 101 | $757.50 | $100.47 | 13.3% |
| J7030 | Infusion, normal saline solution , 1000 cc | Office | 2021 | 14 | 17 | $765.00 | $31.00 | 4.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 16 | 28 | $560.00 | $8.72 | 1.6% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2021 | 13 | 13 | $156.00 | $1.20 | 0.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 485 | 546 | $105,924 | $48,286 | 45.6% |
About Dr. Jeffrey Hassel, MD
Dr. Jeffrey Hassel, MD is a Internal Medicine healthcare provider based in Wyomissing, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1801935903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Hassel, MD has received a total of $959.98 in payments from pharmaceutical and medical device companies, with $20.46 received in 2019. These payments were reported across 74 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($874.98).
As a Medicare-enrolled provider, Hassel has provided services to 6,438 Medicare beneficiaries, totaling 7,117 services with total Medicare billing of $396,927. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Wyomissing, PA
- Active Since 02/05/2007
- Last Updated 08/28/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801935903
Products in Payments
- Victoza (Drug) $121.70
- Myrbetriq (Drug) $118.66
- TOUJEO (Drug) $82.33
- LYRICA (Drug) $82.31
- BEVESPI AEROSPHERE (Drug) $48.79
- ANORO (Drug) $36.05
- VIAGRA (Drug) $31.31
- SOLIQUA (Drug) $23.67
- BREO (Drug) $22.26
- NIOX VERO DEVICE (Device) $18.84
- Tekturna (Drug) $18.68
- NAMZARIC (Drug) $17.78
- JARDIANCE (Drug) $14.61
- RELISTOR ORAL (Drug) $14.59
- VIBERZI (Drug) $13.21
- TSPOT TB TEST (Device) $13.19
- Prolia (Biological) $13.09
- Amitiza (Drug) $12.93
- MENACTRA (Drug) $12.47
- TRULICITY (Drug) $12.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Wyomissing
Philip Elbaum
Internal Medicine — Payments: $11,913
Internal Medicine $11,913
Dr. David Zisa, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $5,530
Internal Medicine $5,530
J Aynardi, M.d, M.D
Internal Medicine — Payments: $5,018
Internal Medicine $5,018
Evan Butlin, M.d, M.D
Internal Medicine — Payments: $4,218
Internal Medicine $4,218
Brigid Ellis, D.o, D.O
Internal Medicine — Payments: $3,592
Internal Medicine $3,592
Dr. Nina Bandyopadhyay, D.o, D.O
Internal Medicine — Payments: $3,473
Internal Medicine $3,473